Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PetVivo Holdings Inc PETV

Healthcare Medical Devices
PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for companion animals. The Company has developed a pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the Company’s biomaterials, products, production processes and methods of use... see more

Recent & Breaking News (OTCQB:PETV)

Mark Middleton Joins PetVivo Holdings, Inc. as the National Director of Sales

GlobeNewswire September 2, 2021

PetVivo Holdings, Inc. to Exhibit at Western Veterinary Conference in Las Vegas, Nevada

GlobeNewswire August 30, 2021

Ann Zieser Joins PetVivo Holdings, Inc. as Senior Technical Veterinarian

GlobeNewswire August 25, 2021

PetVivo Changes Brand Name of Signature Osteoarthritis Product to "SPRYNG"

GlobeNewswire August 23, 2021

Russell Siakel Joins PetVivo Holdings, Inc. as the Director of Marketing

GlobeNewswire August 19, 2021

PetVivo Holdings to Present at Emerging Growth Conference on August 18, 2021

GlobeNewswire August 16, 2021

PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing

GlobeNewswire August 13, 2021

PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing

GlobeNewswire August 10, 2021

PetVivo Awarded Key Biocompatible Stent Patent by the United States Patent and Trademark Office

GlobeNewswire April 28, 2021

Robert J. Folkes Joins PetVivo Holdings, Inc. as Chief Financial Officer

GlobeNewswire April 16, 2021

PetVivo Holdings, Inc. to exhibit at the American Association of Equine Pratitioners Virtual Convention and Trade Show

GlobeNewswire December 7, 2020

PetVivo Holdings, Inc. Announces Sponsored Research Agreement with Colorado State University for Osteoarthritis Treatment Study.

GlobeNewswire November 12, 2020

nScrypt Bioprints PetVivo® Biomaterial for Orthopedic Implants

GlobeNewswire October 20, 2020

Petvivo Holdings, Inc. Announces Opening of State of the Art Medical Device Manufacturing Facility in Edina, Minnesota.

GlobeNewswire October 5, 2020

PETVIVO HOLDINGS, INC. HIRES DR. DAVID B MASTERS AS DIRECTOR OF SCIENCE AND TECHNOLOGY

GlobeNewswire September 10, 2020

PetVivo Announces Notice of Allowance for United States Patent Application Enhancing the Proprietary Coverage of Kush®, a Treatment for Animal Lameness

GlobeNewswire August 6, 2020

Goldman Small Cap Research Issues New Sector Snapshot Featuring PetVivo Holdings, Inc.

ACCESSWIRE IA July 20, 2020

PETVIVO HOLDINGS PROVIDES STAKEHOLDER UPDATE

GlobeNewswire May 13, 2020

Petvivo Holdings, Inc. Announces new social media engagement campaign

GlobeNewswire April 13, 2020

PetVivo Holdings, Inc. exhibits at Western Veterinary Conference in Las Vegas, NV.

GlobeNewswire February 26, 2020